PUXANO has developed a proprietary technology platform which fuses biotechnology, nanotechnology, and AI to revolutionize protein design and structure-based research to get access to those challenging targets where standard workflows fail, such as outer membrane proteins, glycoproteins, GPCRs, ion channels and fragile protein complexes. 

We have build a protein design toolbox for generating soluble analogues, multimer-stabilizing scaffolds, multi-epitope scaffolds, multimer-generating scaffolds or fiducials to build antigens for vaccine and antibody development, facilitate high-throughput drug screening or accelerate structure-guided drug development. 

Via our cryoEM grid portfolio, we can overcome major problems in cryoEM sample preparation: low sample yields, complex dissassembly or preferred particle orientation. Furthermore, this enables to gain access to proteins isolated from patient-derived samples in a reproducible efficient manner.  

We can proudly state that we have accelerated drug discovery pipelines of targets that were blocked in the past and we thrive in making the impossible possible.